Adverse effects of SGLT2 inhibitors on bone

Por Blau, Jenny E., Taylor, Simeon I.
Publicado no Nat Rev Nephrol (2018)

SGLT2 Inhibitors May Predispose to Ketoacidosis

Por Taylor, Simeon I., Blau, Jenny E., Rother, Kristina I.
Publicado no J Clin Endocrinol Metab (2015)

SGLT2-inhibitors Trigger Downstream Mechanisms That May Exert Adverse Effects Upon Bone

Por Taylor, Simeon I., Blau, Jenny E., Rother, Kristina I.
Publicado no Lancet Diabetes Endocrinol (2014)

Understanding the metabolic and health effects of low-calorie sweeteners: methodological considerations and implications for future research

Por Sylvetsky, Allison C., Blau, Jenny E., Rother, Kristina I.
Publicado no Rev Endocr Metab Disord (2016)

Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data

Por Blau, Jenny E., Tella, Sri Harsha, Taylor, Simeon I., Rother, Kristina I.
Publicado no Diabetes Metab Res Rev (2017)

Hormonal responses to non-nutritive sweeteners in water and diet soda

Por Sylvetsky, Allison C., Brown, Rebecca J., Blau, Jenny E., Walter, Mary, Rother, Kristina I.
Publicado no Nutr Metab (Lond) (2016)

Plasma concentrations of sucralose in children and adults

Por Sylvetsky, Allison C., Bauman, Viviana, Blau, Jenny E., Garraffo, H. Martin, Walter, Peter J., Rother, Kristina I.
Publicado no Toxicol Environ Chem (2016)

NONNUTRITIVE SWEETENERS IN BREAST MILK

Por Sylvetsky, Allison C., Gardner, Alexandra L., Bauman, Viviana, Blau, Jenny E., Garraffo, H. Martin, Walter, Peter J., Rother, Kristina I.
Publicado no J Toxicol Environ Health A (2015)

Canagliflozin triggers the FGF23/1,25-dihydroxyvitamin D/PTH axis in healthy volunteers in a randomized crossover study

Por Blau, Jenny E., Bauman, Viviana, Conway, Ellen M., Piaggi, Paolo, Walter, Mary F., Wright, Elizabeth C., Bernstein, Shanna, Courville, Amber B., Collins, Michael T., Rother, Kristina I., Taylor, Simeon I.
Publicado no JCI Insight (2018)